David C. Hastings, Chief Financial Officer at Arbutus Biopharma Corp (ABUS), sold 9,593 shares at $2.31 ($22K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Scheduled sale ($22k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SCYX | BUY | 2017-06-22 | $35K | — | Filing → |
| INCY | SELL | 2014-06-06 | $10.5M | — | Filing → |
| INCY | SELL | 2014-02-18 | $18.1M | — | Filing → |